LRP6 and glioblastoma: Given these results from analyses of TCGA data, we performed USP46 knockdowns in the glioblastoma cell lines, A172 and U87, to determine whether the complex is active in the glioblastoma cell lines and found significant decreases in LRP6 levels in both lines (Supplementary Fig. 10C).